Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.

Related articles

19 Jun 2020 : Clinical Research

Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease

Li Hao, Zhengzhen Wang, [...] Yan Wang, Juan Wang, Zhipeng Zeng - Show fewer authors

DOI: 10.12659/MSM.923015

28 Jun 2020 : Database Analysis

Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction

Weiran Dai, Yue Sun, [...] Zhiyuan Jiang, Kuan Du, Ning Xia, Guoqiang Zhong - Show fewer authors

DOI: 10.12659/MSM.922492

29 Jan 2020 : Case report

Acute Fatty Liver of Pregnancy: Rare, but Potentially Fatal

Andreia de Vasconcelos Gaspar, Tânia C. Ascensão, [...] Isabel Santos Silva - Show fewer authors

DOI: 10.12659/AJCR.921122

23 Dec 2019 : Clinical Research

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study

Alihan Oral, Tolga Sahin, [...] Fatih Turker, Erdem Kocak - Show fewer authors

DOI: 10.12659/MSM.920172

16 Oct 2018 : Laboratory Research

Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease

Zhongyong Zhang, Yueying Qi, [...] Wubao Kong, Qianqian Jin, Xiaoyun Wang, Yanfang Dong, Yuansong Wang, Huajun Li - Show fewer authors

DOI: 10.12659/MSM.911062

26 Nov 2018 : Animal Research

The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN)

Jianlong Gao, Rui Xiong, [...] Dan Xiong, Wenxing Zhao, Sheng Zhang, Tao Yin, Xinhua Zhang, Guozhen Jiang, Zhengyu Yin - Show fewer authors

DOI: 10.12659/MSM.910544

23 Apr 2012

The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania

Jonas Valantinas, Daiva Asta Apanaviciene, [...] Ligita Maroziene, Audrius Sveikata - Show fewer authors

DOI: 10.12659/MSM.882722

23 Apr 2012

Metabolic syndrome and left ventricular function: Is the number of criteria actually important?

Marijana Tadic, Branislava Ivanovic, [...] Nada Kostic, Dragan Simic, Danica Matic, Vera Celic - Show fewer authors

DOI: 10.12659/MSM.882733

26 Mar 2016 : Clinical Research

Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening

Mehtap Evran, Gamze Akkuş, [...] İlayda Berk Bozdoğan, Mustafa Gök, Ali Deniz, Murat Sert, Tamer Tetiker - Show fewer authors

DOI: 10.12659/MSM.897714

24 Nov 2017 : Animal Research

Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats

Hua Fan, Xiande Ma, [...] Peng Lin, Qiang Kang, Zhilong Zhao, Lina Wang, Dan Sun, Jiayi Cheng, Yajun Li - Show fewer authors

DOI: 10.12659/MSM.907530

16 May 2017 : Laboratory Research

MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)

Xianchao An, Zonglin Yang, [...] Zhengzhuang An - Show fewer authors

DOI: 10.12659/MSM.901377

03 May 2017 : Clinical Research

Association Between Alcohol Consumption and Metabolic Syndrome in a Community-Based Cohort of Korean Adults

Su Kang Kim, Seung-Hee Hong, [...] Joo-Ho Chung, Kyu Bong Cho - Show fewer authors

DOI: 10.12659/MSM.901309

11 Apr 2017 : Original article

Application of Indocyanine Green (ICG) Detection in Evaluating Early Prognosis in Patients with Fatty Liver Disease After Liver Transplantation

Wenjing Wang, Qiang Zhao, [...] Anbin Hu, Xiaoshun He, Xiaofeng Zhu - Show fewer authors

DOI: 10.12659/AOT.901277

02 Nov 2016 : Clinical Research

Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients

Yanjin Hu, Jia Liu, [...] Xuejie Dong, Yuan Xu, Song Leng, Guang Wang - Show fewer authors

DOI: 10.12659/MSM.897924

30 Mar 2009

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease

Yusuf Yilmaz, Ozlen Atug, [...] Oya Yonal, Deniz Duman, Osman Ozdogan, Nese Imeryuz, Cem Kalayci - Show fewer authors

14 Aug 2015 : Clinical Research

Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk

Jian-Qin Zhang, Hui Geng, [...] Mao Ma, Xun-Yi Nan, Bin-Wu Sheng - Show fewer authors

DOI: 10.12659/MSM.893442

02 Dec 2014 : Review article

Dulaglutide: A Review of a New Glucagon-Like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus

Mohamed Teleb, Ngamdu Sumayin, [...] Sarmad Said - Show fewer authors

DOI: 10.12659/MSRev.893152

29 Aug 2014 : Original article

Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Olcay Ozveren, Orhan Dogdu, [...] Cihan Sengul, Veysel Cinar, Elif Eroglu, Zekeriya Kucukdurmaz, Muzaffer Degertekin - Show fewer authors

DOI: 10.12659/MSM.890741

16 Dec 2013 : Original article

Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes

Aleksandra Trojak, Małgorzata Waluś-Miarka, [...] Ewa Woźniakiewicz, Maciej T. Małecki, Barbara Idzior-Waluś - Show fewer authors

DOI: 10.12659/MSM.889649

01 Feb 2012

Prevalence of metabolic syndrome in elderly Japanese-Brazilians

Natasha Priscilla Xavier, Rita Cristina Chaim, [...] Suely Godoy Agostinho Gimeno, Sandra Roberta Gouvea Ferreira, Amelia Toyomi Hirai, Camila Moreno Rosa, Carlos Roberto Padovani, Marina Politi Okoshi, Katashi Okoshi - Show fewer authors

DOI: 10.12659/MSM.882448

24 Apr 2011

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

Yasar Colak, Oguzhan Ozturk, [...] Ebubekir Senates, Ilyas Tuncer, Elif Yorulmaz, Gupse Adali, Levent Doganay, Feruze Yilmaz Enc - Show fewer authors

DOI: 10.12659/MSM.881749

01 Dec 2009

Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease

Tatjana Abel, Janos Feher, [...] Elek Dinya, Mohamed Gamal Eldin, Attila Kovacs - Show fewer authors

25 Sep 2009

Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease

Munechika Enjoji, Masatake Tanaka, [...] Masayuki Miyazaki, Nobito Higuchi, Masaki Kato, Kazuhiro Kotoh, Kazuhisa Matsunaga, Takuya Nishinakagawa, Kazuyuki Machida, Manabu Nakashima, Makoto Nakamuta - Show fewer authors